Pulmonális artériás hipertónia: vizsgálatok itt: Egyesült Államok
108 trials · From ClinicalTrials.gov, checked 2026. november 15.. Ask the study team whether a trial fits you.
- No phaseTaking peopleNatural History of Sickle Cell Disease
- Where
- Bethesda, Washington D.C.
- Életkor
- 2 év to 90 év
- People
- 3500
- Run by
- National Heart, Lung, and Blood Institute (NHLBI)
See details and how to joinNCT00081523 - No phaseTaking peopleNatural History Study of Biomarkers in Pulmonary Arterial Hypertension
- Where
- Bethesda
- Életkor
- 18 év to 100 év
- People
- 270
- Run by
- National Institutes of Health Clinical Center (CC)
See details and how to joinNCT01730092 - No phaseTaking peopleA Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease
- Where
- Boston, Cleveland, Detroit, Houma, Manhasset, Mechanicsburg, New Haven, New York, Tucson, Tulsa, Washington D.C., Weston, Wynnewood
- Életkor
- 18 év to 85 év
- People
- 750 worldwide
- Run by
- Pulnovo Medical, Inc.
See details and how to joinNCT07214376 - 3. fázisTaking peopleAn Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Where
- Bend, Naples
- Életkor
- 18 év and over
- People
- 344 worldwide
- Run by
- Insmed Incorporated
See details and how to joinNCT07234032 · EU 2025-521769-29-00 - No phaseTaking peopleUnderstanding the Effects of Pulmonary Arterial Hypertension on Lean Muscle Mass-Substudy
- Where
- Philadelphia
- Életkor
- 18 év and over
- People
- 20
- Run by
- University of Pennsylvania
See details and how to joinNCT07781709 - 2/3. fázisNot yet taking people in Egyesült ÁllamokAn Open-Label Extension Study to Evaluate Inhaled Treprostinil SMI in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD)
- Where
- Boston, Chapel Hill, Charleston, Chicago, Dallas, Detroit, Falls Church, Lexington, Palo Alto, Philadelphia, Phoenix, Pittsburgh, San Francisco, Tucson
- Életkor
- 18 év and over
- People
- 400
- Run by
- United Therapeutics
See details and how to joinNCT07923526 - 2. fázisNot yet taking people in Egyesült ÁllamokStudy of Treprostinil Administered Via Soft Mist Inhaler (SMI) in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD)
- Where
- Birmingham, Boston, Chapel Hill, Charleston, Chicago, Dallas, Detroit, Falls Church, Lexington, Palo Alto, Philadelphia, Phoenix, Pittsburgh, San Francisco, Tucson
- Életkor
- 18 év and over
- People
- 40
- Run by
- United Therapeutics
See details and how to joinNCT07923591 - No phaseTaking peopleTrial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
- Where
- Abington, Albuquerque, Atlanta, Augusta, Austin, Boston, Chapel Hill, Charleston, Charlotte, Charlottesville, Chicago, Cincinnati, Cleveland, Columbia, Dallas, Detroit, Gainesville, Grand Rapids, Hackensack, Hershey, Houston, Indianapolis, Iowa City, Kansas City, Lexington, Little Rock, Louisville, Manhasset, Marietta, Memphis, Milwaukee, Minneapolis, Newark, New York, Oakbrook Terrace, Oklahoma City, Omaha, Philadelphia, Phoenix, Pittsburgh, Plano, Portland, Richmond, Rochester, Sacramento, Salt Lake City, San Francisco, Temple, The Bronx, Tulsa, Washington D.C., Weston
- Életkor
- 18 év and over
- People
- 850 worldwide
- Run by
- Abbott Medical Devices
See details and how to joinNCT06526195 - No phaseTaking peopleRehabilitation Program for People With Methamphetamine-Associated Cardiopulmonary Conditions
- Where
- Salt Lake City
- Életkor
- 18 év and over
- People
- 45
- Run by
- Michael Incze
See details and how to joinNCT07915882 - 2. fázisTaking peopleSpironolactone for Pulmonary Arterial Hypertension
- Where
- Bethesda
- Életkor
- 18 év to 100 év
- People
- 70
- Run by
- National Institutes of Health Clinical Center (CC)
See details and how to joinNCT01712620 - No phaseTaking peopleMulti-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
- Where
- Albuquerque, Ann Arbor, Birmingham, Bossier City, Boston, Buffalo, Charleston, Chicago, Cleveland, Dallas, Denver, Hannibal, Houston, Indianapolis, Jackson, Knoxville, Lexington, Little Rock, Minneapolis, Morgantown, New York, Oklahoma City, Omaha, Orlando, Philadelphia, Phoenix, Reno, Richmond, Riverside, Royal Oak, Salt Lake City, San Antonio, Shreveport, Springfield, Winston-Salem
- Életkor
- 18 év and over
- People
- 900
- Run by
- Tempus AI
See details and how to joinNCT06911632 - 2. fázisTaking peopleStudy to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008)
- Where
- Aurora, Cincinnati, Los Angeles, Milwaukee, Nashville, Palo Alto, Philadelphia, San Francisco, Seattle, Washington D.C.
- Életkor
- 1 év to 17 év
- People
- 42 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT05587712 · EU 2023-504861-22-00 - 1/2. fázisTaking peopleHS235 Study in Overweight and Obese Participants With Combined Pre and Post-Capillary Pulmonary Hypertension Due to Heart Failure With Preserved Ejection Fraction
- Where
- Dallas, Greenville, Kansas City
- Életkor
- 18 év and over
- People
- 126
- Run by
- 35Pharma Inc., a GSK company
See details and how to joinNCT07123779 - 1/2. fázisTaking peopleA Study of HS235 for Treatment of Pulmonary Arterial Hypertension (PAH) in Adults
- Where
- Boston, Providence, Tampa
- Életkor
- 18 év and over
- People
- 90 worldwide
- Run by
- 35Pharma Inc., a GSK company
See details and how to joinNCT07143448 - 4. fázisTaking peopleDe-implementing Inhaled Nitric Oxide for Congenital Diaphragmatic Hernia
- Where
- Ann Arbor, Atlanta, Aurora, Birmingham, Boston, Charleston, Houston, Indianapolis, Irvine, Little Rock, Los Angeles, Louisville, Memphis, Nashville, Palo Alto, Portland, Salt Lake City, San Diego, Seattle
- Életkor
- 0 hónap to 1 hónap
- People
- 900
- Run by
- The University of Texas Health Science Center, Houston
See details and how to joinNCT05213676 - 2. fázisTaking peopleA Clinical Trial of NS-863 in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Where
- Knoxville
- Életkor
- 18 év to 80 év
- People
- 177 worldwide
- Run by
- NS Pharma, Inc.
See details and how to joinNCT07441278 - 2. fázisTaking peopleStudy of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease
- Where
- Allen Park, Boise, Phoenix, San Francisco
- Életkor
- 18 év to 80 év
- People
- 25 worldwide
- Run by
- Tectonic Operating Company, Inc.
See details and how to joinNCT07473700 - No phaseTaking peopleVentilator Pressure and Optimization of Compliance and Hemodynamics
- Where
- Birmingham
- Életkor
- 7 nap to 30 nap
- People
- 24
- Run by
- University of Alabama at Birmingham
See details and how to joinNCT06512935 - 3. fázisTaking peopleEfficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Where
- Bend, Chapel Hill, Cincinnati, Durham, Fresno, Gainesville, Kansas City, Los Angeles, Naples, New York, Philadelphia, Phoenix, Richmond, Salt Lake City, San Francisco, Santa Barbara, St. Petersburg, Tampa
- Életkor
- 18 év and over
- People
- 344 worldwide
- Run by
- Insmed Incorporated
See details and how to joinNCT07179380 · EU 2025-521558-40-00 - 2. fázisTaking peopleStudy of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH)
- Where
- Aurora, Boston, Cincinnati, Omaha
- Életkor
- 18 év and over
- People
- 99 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT07318597 · EU 2024-514754-79-00 - 3. fázisTaking peopleFibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging
- Where
- Bethesda
- Életkor
- 18 év to 100 év
- People
- 210
- Run by
- National Heart, Lung, and Blood Institute (NHLBI)
See details and how to joinNCT07613099 - 2. fázisNot yet taking people in Egyesült ÁllamokPhase IIA Study of Belzutifan in EPAS1-, EGLN1-, or VHL-Mutant Erythrocytosis
- Where
- Salt Lake City
- Életkor
- 18 év and over
- People
- 16
- Run by
- University of Utah
See details and how to joinNCT07895966 - No phaseTaking peoplePulmonary Hypertension (PH) Biorepository for Translational Research
- Where
- Baltimore, Bethesda, Falls Church
- Életkor
- 18 év to 100 év
- People
- 1000
- Run by
- National Institutes of Health Clinical Center (CC)
See details and how to joinNCT07647549 - 2. fázisNot yet taking people in Egyesült ÁllamokLAM-001 for the Treatment of Sarcoidosis Associated Pulmonary Hypertension (SAPH)
- Where
- Philadelphia
- Életkor
- 18 év to 80 év
- People
- 60
- Run by
- IRulya Therapeutics Inc.
See details and how to joinNCT07886554 - 3. fázisCsak meghívásosLong-Term Open-Label Extension Study of Oral Levosimendan
- Where
- Boston, Charleston, Chicago, Durham, Madison, Minneapolis, New York, Omaha, Rochester, St Louis
- Életkor
- 18 év and over
- People
- 800
- Run by
- Tenax Therapeutics, Inc.
See details and how to joinNCT07436689